REFERENCES
1. Morrow M, Van Zee KJ, Patil S, et al. Axillary dissection and nodal irradiation can be avoided for most node-positive Z0011-eligible breast cancers: a prospective validation study of 793 patients. Ann Surg 2017;266:457-62.
2. Giuliano AE. The evolution of sentinel node biopsy for breast cancer: personal experience. Breast J 2020;26:17-21.
3. Morton DL, Thompson JF, Cochran AJ, et al; MSLT Group. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014;370:599-609.
4. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-90.
5. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33.
6. Lyman GH, Giuliano AE, Somerfield MR, et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
7. Caldonazzi N, Rizzo PC, Eccher A, et al. Value of artificial intelligence in evaluating lymph node metastases. Cancers 2023;15:2491.
8. Peek G, Ross SB. The future implementation of artificial intelligence technology in esophageal surgery. Art Int Surg 2023;3:249-54.
9. Kitagawa Y, Uno T, Oyama T, et al. Esophageal Cancer Practice Guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus 2019;16:1-24.
10. Kato H, Miyazaki T, Nakajima M, et al. Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 2003;98:932-9.
11. Yasuda S, Shimada H, Chino O, et al. Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer. Jpn J Clin Oncol 2003;33:68-72.
12. Prenzel KL, Bollschweiler E, Schröder W, et al. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg 2010;90:1662-7.
13. Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma patients undergoing upfront surgery: a systematic review. Cancers 2020;12:1592.
14. Nagaraja V, Eslick GD, Cox MR. Sentinel lymph node in oesophageal cancer-a systematic review and meta-analysis. J Gastrointest Oncol 2014;5:127-41.
15. Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000;80:1799-809.
16. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
17. Manner H, Wetzka J, May A, et al. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b
18. Gockel I, Sgourakis G, Lyros O, et al. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol 2011;5:371-84.
19. Newton AD, Predina JD, Xia L, et al. Surgical management of early-stage esophageal adenocarcinoma based on lymph node metastasis risk. Ann Surg Oncol 2018;25:318-25.
20. Yang Y, Li Y, Qin J, et al. Mapping of lymph node metastasis from thoracic esophageal cancer: a retrospective study. Ann Surg Oncol 2022;29:5681-8.
21. Hosch SB, Stoecklein NH, Pichlmeier U, et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 2001;19:1970-5.
22. Feith M, Stein HJ, Siewert JR. Pattern of lymphatic spread of Barrett’s cancer. World J Surg 2003;27:1052-7.
23. Guidozzi N, Menon N, Chidambaram S, Markar SR. The role of artificial intelligence in the endoscopic diagnosis of esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2023;36:doad048.
24. Gómez B, Milla Collado L, Rodríguez M. Artificial intelligence in esophageal cancer diagnosis and treatment: where are we now? - a narrative review. Ann Transl Med 2023;11:353.
25. Cykowska A, Marano L, D’Ignazio A, et al. New technologies in breast cancer sentinel lymph node biopsy; from the current gold standard to artificial intelligence. Surg Oncol 2020;34:324-35.
26. Liu Y, Kohlberger T, Norouzi M, et al. Artificial intelligence-based breast cancer nodal metastasis detection: insights into the black box for pathologists. Arch Pathol Lab Med 2019;143:859-68.
27. Oliver JR, Karadaghy OA, Fassas SN, Arambula Z, Bur AM. Machine learning directed sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck 2022;44:975-88.
28. Kan T, Shimada Y, Sato F, et al. Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol 2004;11:1070-8.
29. Zhang YH, Guo LJ, Yuan XL, Hu B. Artificial intelligence-assisted esophageal cancer management: now and future. World J Gastroenterol 2020;26:5256-71.
30. Obermannová R, Alsina M, Cervantes A, et al; ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022;33:992-1004.
31. Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2023;21:393-422.
32. van der Werf LR, Busweiler LAD, van Sandick JW, van Berge Henegouwen MI, Wijnhoven BPL; Dutch Upper GI Cancer Audit (DUCA) group. Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg 2020;271:1095-101.
33. Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 2012;107:850-62.
34. Nieuwenhuis EA, van Munster SN, Meijer SL, et al; Dutch Barrett Expert Centers. Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinoma. Gastrointest Endosc 2022;96:237-47.e3.
35. Kamarajah SK, Phillips AW, Hanna GB, Low DE, Markar SR. Is local endoscopic resection a viable therapeutic option for early clinical stage T1a and T1b esophageal adenocarcinoma? A propensity-matched analysis. Ann Surg 2022;275:700-5.
36. Altorki NK, Lee PC, Liss Y, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg 2008;247:434-9.
37. Künzli HT, Belghazi K, Pouw RE, et al. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J 2018;6:669-77.
38. Schölvinck D, Künzli H, Meijer S, et al. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc 2016;30:4102-13.
39. Takeuchi H, Kitagawa Y. Sentinel node navigation surgery in esophageal cancer. Ann Gastroenterol Surg 2019;3:7-13.
40. Overwater A, Weusten BLAM, Ruurda JP, et al. Feasibility of sentinel node navigated surgery in high-risk T1b esophageal adenocarcinoma patients using a hybrid tracer of technetium-99 m and indocyanine green. Surg Endosc 2022;36:2671-9.
41. Künzli HT, van Berge Henegouwen MI, Gisbertz SS, et al. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients. Dis Esophagus 2017;30:1-8.
42. Frederiks CN, Overwater A, Bergman JJGHM, et al. Feasibility and safety of tailored lymphadenectomy using sentinel node-navigated surgery in patients with high-risk T1 esophageal adenocarcinoma. Ann Surg Oncol 2023;30:4002-11.
43. Uenosono Y, Arigami T, Yanagita S, et al. Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer. Ann Surg Oncol 2011;18:2003-9.
